Rick Doblin Shares How Psychedelics Ease Suffering At End Of Life

2021 ⸱ 

Rick Doblin, PhD

Share

While still in college, Rick Doblin dedicated his life to researching and championing psychedelics as medicines for therapeutic and personal growth. Through his work as a therapist, Rick has had the privilege to witness the impact psychedelics have made at the end of his clients’ lives and now offers us a vision for how we might bring these therapies into hospice settings and beyond.

About the speaker(s)

Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. Today, MAPS is designing or sponsoring psychedelic psychotherapy drug development research in over a dozen countries and has raised more than $70 million in donations.

Help us change the way we die

Join the Movement

Get the latest news and fresh ideas from the frontlines of all things end of life.